GLP-1 receptor agonists have now received FDA approvals for cardiovascular risk reduction, obstructive sleep apnea, and chronic kidney disease, in addition to their original diabetes and obesity indications
Spiking Glucose During Ketosis (00:59:13) Metabolic Efficiency, Matching Nutrition to Training, Needs Based Eating (01:05:00) Duncans Work with Olympic Athletes, NCAA, UFC (Ultimate Fighting Championship) (01:08:00) Why UFC & MMA (Mixed-Martial Arts) Are So Valuable for Advancing Performance (01:12:40) Voluntarily Switching Between Different States of Arousal (01:14:30) Heat, Getting Better at Sweating, Heat Shock Proteins, Sauna (01:20:12) Using Rotating 12-Week Training Programs
Kaehler KC, Russo PAJ, Katenkamp D, Kreusch T, Neuber K, Schwarz T, et al
Diabetes 47 , 374380 (1998)
What can vary by case Whether a prescription is approved following clinician review
Join us and make this journey the one that sticks